Search Results

There are 3423 results for: content related to: Genetic and catalytic efficiency structure of an HCV protease quasispecies

  1. Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism

    Hepatology Research

    Yoshihito Uchida, Jun-ichi Kouyama, Kayoko Naiki, Kayoko Sugawara, Mie Inao, Yukinori Imai, Nobuaki Nakayama and Satoshi Mochida

    Version of Record online : 30 MAR 2016, DOI: 10.1111/hepr.12673

  2. Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection

    Journal of Viral Hepatitis

    Volume 8, Issue 1, January 2001, Pages: 1–18, Ke-Qin Hu, John M. Vierling and Allan G. Redeker

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1365-2893.2001.00253.x

  3. Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy

    Journal of Viral Hepatitis

    Volume 8, Issue 2, March 2001, Pages: 120–131, F. Querenghi, Qiang Yu, G. Billaud, G. Maertens, C. Trépo and F. Zoulim

    Version of Record online : 15 DEC 2003, DOI: 10.1046/j.1365-2893.2001.00265.x

  4. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma

    Liver International

    Volume 27, Issue 8, October 2007, Pages: 1126–1133, Maria Stella De Mitri, Romina Cassini, Sabrina Bagaglio, Giulia Morsica, Pietro Andreone, Nicoletta Marino and Mauro Bernardi

    Version of Record online : 16 AUG 2007, DOI: 10.1111/j.1478-3231.2007.01537.x

  5. You have free access to this content
    Poster Session 2: HCV Virology and Pathogenesis

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 690A–713A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28220

  6. Hepatitis C virus: The role of molecular mimicry in response to interferon treatment

    Journal of Medical Virology

    Volume 84, Issue 10, October 2012, Pages: 1571–1585, Samra Uzicanin, Yu-Wen Hu, Husam Alsousi, Martin Pelchat, Lynda Rocheleau, Rama C. Nair and Earl G. Brown

    Version of Record online : 15 AUG 2012, DOI: 10.1002/jmv.23361

  7. Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?

    Journal of Viral Hepatitis

    Volume 9, Issue 5, September 2002, Pages: 360–369, G. Squadrito, G. Raffa, T. Restuccia, T. Pollicino, S. Brancatelli and G. Raimondo

    Version of Record online : 10 SEP 2002, DOI: 10.1046/j.1365-2893.2002.00379.x

  8. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  9. You have free access to this content
    HCV: Virology

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 926A–943A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26868

  10. A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy

    Journal of Medical Virology

    Volume 84, Issue 12, December 2012, Pages: 1913–1919, Hejun Yuan, Beverley Adams-Huet, Tianna Petersen, Nahid Attar, William M. Lee and Mamta K. Jain

    Version of Record online : 10 OCT 2012, DOI: 10.1002/jmv.23407

  11. Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?

    Journal of Viral Hepatitis

    Volume 14, Issue 2, February 2007, Pages: 96–106, S. Vallet, S. Gouriou, G. Nkontchou, H. Hotta, M. Vilerio, M. C. Legrand-Quillien, M. Beaugrand, J. C. Trinchet, J. B. Nousbaum, P. Dény, C. Gaudy, A. Goudeau, B. Picard and C. Payan

    Version of Record online : 2 AUG 2006, DOI: 10.1111/j.1365-2893.2006.00773.x

  12. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis

    Hepatology Research

    Volume 38, Issue 1, January 2008, Pages: 1–26, Aldona Kasprzak and Agnieszka Adamek

    Version of Record online : 25 SEP 2007, DOI: 10.1111/j.1872-034X.2007.00261.x

  13. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients

    Journal of Viral Hepatitis

    Volume 21, Issue 6, June 2014, Pages: e19–e28, M. Nevot, C. Boesecke, M. Parera, C. Andrés, S. Franco, B. Revollo, P. Ingiliz, C. Tural, B. Clotet, J. K. Rockstroh, M. A. Martinez and the NEAT study group

    Version of Record online : 27 MAR 2014, DOI: 10.1111/jvh.12254

  14. You have free access to this content
    Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs

    Hepatology

    Volume 49, Issue 2, February 2009, Pages: 364–377, Judith M. Gottwein, Troels K. H. Scheel, Tanja B. Jensen, Jacob B. Lademann, Jannick C. Prentoe, Maria L. Knudsen, Anne M. Hoegh and Jens Bukh

    Version of Record online : 9 OCT 2008, DOI: 10.1002/hep.22673

  15. Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity

    Journal of Viral Hepatitis

    Volume 15, Issue 6, June 2008, Pages: 459–470, H. Yu, L. A. Babiuk and S. Van Drunen Littel-van den Hurk

    Version of Record online : 24 JAN 2008, DOI: 10.1111/j.1365-2893.2008.00959.x

  16. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  17. You have free access to this content
    Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma

    International Journal of Cancer

    Volume 107, Issue 1, 20 October 2003, Pages: 65–73, Yih-Lin Chung, Meei-Ling Sheu and Sang-Hue Yen

    Version of Record online : 11 JUL 2003, DOI: 10.1002/ijc.11303

  18. Natural Genetic Engineering of Hepatitis C Virus NS5A for Immune System Counterattack

    Annals of the New York Academy of Sciences

    Volume 1178, Issue 1, October 2009, Pages: 173–185, Mahmoud M. El Hefnawi, Wessam H. El Behaidy, Aliaa A. Youssif, Atek Z. Ghalwash, Lamya A. El Housseiny and Suher Zada

    Version of Record online : 15 OCT 2009, DOI: 10.1111/j.1749-6632.2009.05003.x

  19. You have free access to this content
    The Hepatitis C Virus Non-Structural Protein NS5A Alters the Trafficking Profile of the Epidermal Growth Factor Receptor

    Traffic

    Volume 9, Issue 9, September 2008, Pages: 1497–1509, Jamel Mankouri, Stephen Griffin and Mark Harris

    Version of Record online : 10 JUN 2008, DOI: 10.1111/j.1600-0854.2008.00779.x

  20. You have free access to this content
    Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: Implication of genotypic difference in interferon treatment

    FEBS Letters

    Volume 584, Issue 18, September 24, 2010, Pages: 4069–4076, Sang-Min Kang, Seung-Jae Won, Gun-Hee Lee, Yun-Sook Lim and Soon B. Hwang

    Version of Record online : 22 SEP 2010, DOI: 10.1016/j.febslet.2010.08.032